Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Brain Neoplasms 2Pinealoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Multiple Sclerosis 1Meningioma 1Medulloblastoma 1Lymphoma 1Liver Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Ependymoma 1Choroid Plexus Neoplasms 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

Cyclophosphamide 25Rituximab 18fludarabine phosphate 15Radiotherapy 13Methotrexate 13Peripheral Blood Stem Cell Transplantation 12Filgrastim 12Cytarabine 12Vincristine 11Melphalan 10Cyclosporine 10Busulfan 10Antilymphocyte Serum 10Exercise 9Doxorubicin 9Prednisone 7Mycophenolic Acid 7Magnetic Resonance Spectroscopy 7Etoposide 7Early Intervention, Educational 7Whole-Body Irradiation 6Surveys and Questionnaires 6Prednisolone 6Palliative Care 6Methods 6Leucovorin 6Educational Status 6Blood Specimen Collection 6Dexamethasone 5pegylated granulocyte colony-stimulating factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma × gadobenic acid × Clear all
NCT04132843 2022-11-21

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

M.D. Anderson Cancer Center

Phase NA Completed
6 enrolled
CNSLymphoid

Brain Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡